In end-of-life care, polypharmacy can contribute to nausea and vomiting. Which statement best describes its impact on appetite?

• A. Medications may induce vomiting, nausea, or constipation
• B. Medications consistently improve gastric emptying
• C. Medications prevent protein aversions
• D. Medications cure tumors causing aversions

Answer: (A)

In this context, the key idea is that taking many medications can produce GI side effects that blunt appetite. Nausea and vomiting directly reduce the desire to eat, and constipation can cause abdominal discomfort and fullness, both of which further depress intake. Because polypharmacy increases the likelihood of these GI symptoms, the statement that medications may induce vomiting, nausea, or constipation best describes its impact on appetite.

The other ideas don’t fit as well. Medications do not consistently improve gastric emptying for everyone, since drug effects on motility vary widely among individuals. Nor is there a general mechanism by which drugs prevent aversions to protein, and they certainly do not cure tumors that might cause such aversions. The practical takeaway is that the appetite-suppressing effect in end-of-life care is often driven by medication-induced GI symptoms.